External Beam Radiation for Prostate Cancer Increases Risk of Hip Fracture
bdhilton
Member Posts: 813 Member
http://copingmag.com/cwc/index.php/resources/news_article/external_beam_radiation_for_prostate_cancer/
External Beam Radiation for Prostate Cancer Increases Risk of Hip Fracture
May 30 2010
San Francisco, CA – Patients undergoing three dimensional external beam radiation therapy (3D-EBRT) for prostate cancer may be at an increased risk of hip fracture and could benefit from additional measures to improve bone health following treatment, according to a study from researchers in Minneapolis. The data was presented during the 105th Annual Scientific Meeting of the American Urological Association (AUA).
Fractures can impact a patient’s quality of life and mortality, and fracture risk is a well-known concern in prostate cancer patients who undergo androgen suppression therapy (AST), which is known to weaken bones. EBRT has been shown to increase hip-fracture risk in women, and researchers explored whether EBRT impacted a man’s risk and, if so, whether this effect extended beyond the radiation field.
Researchers identified 166,162 prostate cancer patients, ages 66 years and older, in the Surveillance, Epidemiology and End Results (SEER) database and compared hip fracture risk (inside the radiation field) vs. wrist fracture risk (outside the radiation field) in those who had undergone EBRT and those who had not. After controlling for those who were undergoing AST, as well as other risk factors including osteoporosis, race and age, researchers determined that undergoing EBRT increased a man’s risk of hip fracture by 58 percent, without increasing the risk of wrist fracture. Patients being treated with AST had an increased risk of both types of break.
“Maintaining bone health is an important part of treating prostate cancer patients, particularly those on AST,” said Jeff Holzbeierlein, MD, an AUA spokesman. “These data suggest that we might consider taking similar measures with our patients who are receiving three dimensional external beam radiation therapy.”
♦ ♦ ♦ ♦ ♦
External Beam Radiation for Prostate Cancer Increases Risk of Hip Fracture
May 30 2010
San Francisco, CA – Patients undergoing three dimensional external beam radiation therapy (3D-EBRT) for prostate cancer may be at an increased risk of hip fracture and could benefit from additional measures to improve bone health following treatment, according to a study from researchers in Minneapolis. The data was presented during the 105th Annual Scientific Meeting of the American Urological Association (AUA).
Fractures can impact a patient’s quality of life and mortality, and fracture risk is a well-known concern in prostate cancer patients who undergo androgen suppression therapy (AST), which is known to weaken bones. EBRT has been shown to increase hip-fracture risk in women, and researchers explored whether EBRT impacted a man’s risk and, if so, whether this effect extended beyond the radiation field.
Researchers identified 166,162 prostate cancer patients, ages 66 years and older, in the Surveillance, Epidemiology and End Results (SEER) database and compared hip fracture risk (inside the radiation field) vs. wrist fracture risk (outside the radiation field) in those who had undergone EBRT and those who had not. After controlling for those who were undergoing AST, as well as other risk factors including osteoporosis, race and age, researchers determined that undergoing EBRT increased a man’s risk of hip fracture by 58 percent, without increasing the risk of wrist fracture. Patients being treated with AST had an increased risk of both types of break.
“Maintaining bone health is an important part of treating prostate cancer patients, particularly those on AST,” said Jeff Holzbeierlein, MD, an AUA spokesman. “These data suggest that we might consider taking similar measures with our patients who are receiving three dimensional external beam radiation therapy.”
♦ ♦ ♦ ♦ ♦
0
Comments
Discussion Boards
- 120.1K All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 120.3K Cancer specific
- 2.8K Anal Cancer
- 437 Bladder Cancer
- 302 Bone Cancers
- 1.6K Brain Cancer
- 28.3K Breast Cancer
- 384 Childhood Cancers
- 27.8K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.1K Gynecological Cancers (other than ovarian and uterine)
- 12.7K Head and Neck Cancer
- 6.3K Kidney Cancer
- 654 Leukemia
- 772 Liver Cancer
- 4.1K Lung Cancer
- 5K Lymphoma (Hodgkin and Non-Hodgkin)
- 228 Multiple Myeloma
- 7.1K Ovarian Cancer
- 39 Pancreatic Cancer
- 481 Peritoneal Cancer
- 5.1K Prostate Cancer
- 1.2K Rare and Other Cancers
- 528 Sarcoma
- 699 Skin Cancer
- 640 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.7K Uterine Cancer
- 6.2K Other Discussion Boards